Tci Wealth Advisors, Inc. Reata Pharmaceuticals Inc Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$30.85 - $93.17 $1,203 - $3,633	39 New	39 $3,000
Q4 2021 Jan 24, 2022	BUY	$25.61 - $110.96 $2,074 - $8,987	81 Added 139.66%	139 $4,000
Q3 2021 Oct 29, 2021	BUY	$100.0 - $143.02 $2,800 - $4,004	28 Added 93.33%	58 $6,000
Q2 2021 Aug 02, 2021	BUY	$78.27 - $151.29 $2,348 - $4,538	30 New	30 $4,000
Q1 2021 Apr 29, 2021	SELL	$94.25 - $132.81 $1,036 - $1,460	-11 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$102.03 - $184.62 $1,122 - $2,030	11 New	11 $1,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.